Caledonia Mining Q&A: Expanding the business into a multi-asset operation in Zimbabwe (LON:CMCL) 8 January 2021
Touchstone Exploration Q&A: Multi-billion dollar contract over the next 20 years (LON:TXP) 22 December 2020
Caledonia Mining Q&A: Connemara North in a major gold hub & prospective territory (LON:CMCL) 21 December 2020
TEAM plc CIO Flags 20% Plus Returns, AI Capex Doubts and Looming Inflation Shock (Video) 16 February 2026
Diverse Income Trust Plc reports 8.5% H1 returns and review of redemptions and discount 13 February 2026
AstraZeneca’s Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis 18 September 2024
Kingfisher Plc H1 results in line with expectations, market share gains in UK and Poland 17 September 2024
Capital Gearing Trust PLC ORD 2 (CGT.L): Navigating Market Stability with a Robust Portfolio 18 February 2026
Burberry Group PLC (BRBY.L) Stock Analysis: Navigating Challenges with Strategic Resilience in the Luxury Goods Sector 18 February 2026
CALEDONIA INVESTMENTS PLC ORD 0 (CLDN.L): Analyst Consensus Reveals Promising Buy Rating 18 February 2026
Computacenter PLC (CCC.L): Investor Outlook Reveals 16% Upside Potential Amid Robust Revenue Growth 18 February 2026
Bytes Technology Group PLC (BYIT.L) Stock Analysis: Unpacking a Potential 69% Upside 18 February 2026
Caledonia Mining Q&A: Expanding the business into a multi-asset operation in Zimbabwe (LON:CMCL) 8 January 2021
Touchstone Exploration Q&A: Multi-billion dollar contract over the next 20 years (LON:TXP) 22 December 2020
Caledonia Mining Q&A: Connemara North in a major gold hub & prospective territory (LON:CMCL) 21 December 2020
TEAM plc CIO Flags 20% Plus Returns, AI Capex Doubts and Looming Inflation Shock (Video) 16 February 2026
Diverse Income Trust Plc reports 8.5% H1 returns and review of redemptions and discount 13 February 2026
AstraZeneca’s Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis 18 September 2024
Kingfisher Plc H1 results in line with expectations, market share gains in UK and Poland 17 September 2024
Capital Gearing Trust PLC ORD 2 (CGT.L): Navigating Market Stability with a Robust Portfolio 18 February 2026
Burberry Group PLC (BRBY.L) Stock Analysis: Navigating Challenges with Strategic Resilience in the Luxury Goods Sector 18 February 2026
CALEDONIA INVESTMENTS PLC ORD 0 (CLDN.L): Analyst Consensus Reveals Promising Buy Rating 18 February 2026
Computacenter PLC (CCC.L): Investor Outlook Reveals 16% Upside Potential Amid Robust Revenue Growth 18 February 2026
Bytes Technology Group PLC (BYIT.L) Stock Analysis: Unpacking a Potential 69% Upside 18 February 2026
Alphatec Holdings, Inc. (ATEC) Stock Analysis: Strong Revenue Growth and Analyst Confidence Highlight Investment Potential 2 December 2025
Edgewise Therapeutics (EWTX) Stock Analysis: Exploring a 51% Potential Upside in the Biotech Sector 2 December 2025
Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A High-Stakes Play in Biotech with 5.90% Potential Upside 2 December 2025
Clover Health Investments, Corp (CLOV): Growth Potential and Analyst Outlook for Healthcare Investors 2 December 2025
Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Challenges with Growth Potential in Healthcare 2 December 2025
ImmunityBio, Inc. (IBRX) Stock Analysis: Exploring a Biotech Gem with a 343% Potential Upside 2 December 2025
Phreesia, Inc. (PHR) Stock Analysis: Unveiling a 67.73% Potential Upside in Health Information Services 2 December 2025
MoonLake Immunotherapeutics (MLTX): Exploring Growth Potential in the Biotech Sector with a 10% Upside 2 December 2025
Indivior PLC (INDV) Stock Analysis: Navigating a 9.27% Potential Upside with Strategic Growth in Opioid Treatment 2 December 2025
Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: A Biotech with a 146.70% Revenue Growth Surge and Promising Buy Ratings 2 December 2025
Ascentage Pharma Group International (AAPG): Investor Outlook Reveals 38.89% Potential Upside in the Biotechnology Sector 2 December 2025
Immunocore Holdings plc (IMCR) Stock Analysis: Exploring a Potential 69.97% Upside in the Biotech Sector 2 December 2025
Select Medical Holdings Corp (SEM) Stock Analysis: Unpacking a 20% Upside Potential for Informed Investors 2 December 2025
Perrigo Company plc (PRGO) Stock Analysis: Exploring a 55% Potential Upside with a High Dividend Yield 2 December 2025
Arcellx, Inc. (ACLX) Stock Analysis: Harnessing Biotech Potential with a 60.96% Upside 2 December 2025
Beam Therapeutics Inc. (BEAM) Stock Analysis: Navigating a 90% Potential Upside in the Biotech Arena 2 December 2025
Biohaven Ltd. (BHVN) Stock Analysis: Unpacking a 122.64% Upside Potential in the Biotechnology Sector 2 December 2025
SimplyBiz Buyers recognising the quality of SBIZ’s Core revenues and earnings (Analyst Interview) 29 January 2021
Vodafone Group Plc reports Improved Financial Performance & Transformation Gaining Momentum 14 May 2024
Computacenter plc Q1 trading update reports challenges in UK, strong pipeline in N. America 1 May 2024
Caledonia Mining Q&A: Expanding the business into a multi-asset operation in Zimbabwe (LON:CMCL) 8 January 2021
Touchstone Exploration Q&A: Multi-billion dollar contract over the next 20 years (LON:TXP) 22 December 2020
Caledonia Mining Q&A: Connemara North in a major gold hub & prospective territory (LON:CMCL) 21 December 2020
TEAM plc CIO Flags 20% Plus Returns, AI Capex Doubts and Looming Inflation Shock (Video) 16 February 2026
Diverse Income Trust Plc reports 8.5% H1 returns and review of redemptions and discount 13 February 2026
Capital Gearing Trust PLC ORD 2 (CGT.L): Navigating Market Stability with a Robust Portfolio 18 February 2026
Burberry Group PLC (BRBY.L) Stock Analysis: Navigating Challenges with Strategic Resilience in the Luxury Goods Sector 18 February 2026
CALEDONIA INVESTMENTS PLC ORD 0 (CLDN.L): Analyst Consensus Reveals Promising Buy Rating 18 February 2026
Computacenter PLC (CCC.L): Investor Outlook Reveals 16% Upside Potential Amid Robust Revenue Growth 18 February 2026
Bytes Technology Group PLC (BYIT.L) Stock Analysis: Unpacking a Potential 69% Upside 18 February 2026
